Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)

Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22,869	1,812	2,732	9,189	19,215	5,555
Short-Term Investments	2,056	10,000	16,000	13,010	-	1,500
Cash & Short-Term Investments	24,925	11,812	18,732	22,199	19,215	7,055
Cash Growth	59.86%	-36.94%	-15.62%	15.53%	172.36%	123.10%
Accounts Receivable	715.25	446.21	1,277	7,628	11,035	18,072
Other Receivables	882.26	19.54	50.97	55.15	2,414	664.35
Receivables	1,670	465.75	1,671	8,825	17,250	19,386
Inventory	689.15	2,588	2,946	3,350	4,215	6,080
Prepaid Expenses	176	204.45	568.66	337.92	195	466.39
Other Current Assets	3,458	92.36	93.33	138.65	985	281.58
Total Current Assets	30,918	15,163	24,012	34,851	41,860	33,269
Property, Plant & Equipment	5,326	2,904	6,376	6,073	6,674	7,196
Long-Term Investments	3,501	1,593	1,469	4,930	4,875	2,959
Other Intangible Assets	32,203	31,170	33,175	33,664	39,395	19,409
Other Long-Term Assets	13,261	914.36	1,268	929.34	877.22	856.36
Total Assets	105,703	52,792	67,327	80,528	93,741	64,220
Accounts Payable	478.28	430.52	686.72	191.61	178.17	827.76
Accrued Expenses	773.13	141.71	141.35	123.66	143.59	172.37
Short-Term Debt	35,767	5,400	5,900	14,014	6,400	11,606
Current Portion of Long-Term Debt	-	-	111.08	833.32	833.36	500
Current Portion of Leases	623.39	114.1	196.17	354.1	369.82	282.08
Other Current Liabilities	5,008	860.43	1,957	1,744	1,652	1,145
Total Current Liabilities	42,650	6,947	8,992	17,261	9,577	14,533
Long-Term Debt	-	-	-	111.08	29,112	1,000
Long-Term Leases	243.04	32.43	41.7	174.69	423.22	85.99
Long-Term Deferred Tax Liabilities	-	-	-	1,296	2,073	449.55
Other Long-Term Liabilities	2,079	541.56	57.23	57.23	15	15
Total Liabilities	45,168	7,521	9,091	18,957	41,403	16,463
Common Stock	19,911	19,905	19,841	19,330	17,958	17,323
Additional Paid-In Capital	39,797	38,827	145,476	133,406	104,930	93,682
Retained Earnings	-9,268	-12,812	-106,288	-90,481	-70,430	-62,170
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04	-4.04
Comprensive Income & Other	-941.13	-645.72	-789.52	-680.57	-116.86	-1,073
Shareholders' Equity	60,535	45,271	58,235	61,571	52,338	47,758
Total Liabilities & Equity	105,703	52,792	67,327	80,528	93,741	64,220
Total Debt	36,634	5,547	6,249	15,488	37,138	13,474
Net Cash (Debt)	-11,709	6,265	12,483	6,712	-17,923	-6,419
Net Cash Growth	-	-49.81%	86.00%	-	-	-
Net Cash Per Share	-294.01	157.52	317.10	181.81	-499.06	-185.28
Filing Date Shares Outstanding	39.82	39.81	39.68	38.66	35.91	34.64
Total Common Shares Outstanding	39.82	39.81	39.68	38.66	35.91	34.64
Working Capital	-11,732	8,216	15,020	17,590	32,283	18,736
Book Value Per Share	1242.99	1137.24	1467.61	1592.73	1457.32	1378.55
Tangible Book Value	-2,043	14,101	25,061	27,906	12,943	28,349
Tangible Book Value Per Share	-51.32	354.23	631.56	721.89	360.39	818.31
Land	1,100	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	5,190	5,190	5,190	5,190
Machinery	11,291	10,435	11,644	13,822	13,822	13,822
Construction In Progress	-	16	773.4	225	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.